Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

2-amino-5-phosphonovalerate has been researched along with Anti-N-Methyl-D-Aspartate Receptor Encephalitis in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koch, H1
Niturad, CE1
Theiss, S1
Bien, CG1
Elger, C1
Wandinger, KP1
Vincent, A1
Malter, M1
Körtvelyessy, P1
Lerche, H1
Dihné, M1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

ArticleYear
In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients.
    Scientific reports, 2019, 04-03, Volume: 9, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Cerebrospinal

2019